BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
51316882	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)n1cc(nn1)C1CC1 |r|	InChI=1S/C20H26N6O3/c1-22-19(27)17-8-15(26-11-16(23-24-26)12-3-4-12)10-25(17)20(28)13-5-6-14(9-21)18(7-13)29-2/h5-7,11-12,15,17H,3-4,8-10,21H2,1-2H3,(H,22,27)	VCRLFUQSJVUXSF-UHFFFAOYSA-N	50533252	CHEMBL4457012	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533252	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533252&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155526172	440741834							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316883	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Coagulation factor X	Homo sapiens		 72000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316884	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)n1cc(nn1)C1CC1 |r|	InChI=1S/C20H26N6O3/c1-22-19(27)17-8-15(26-11-16(23-24-26)12-3-4-12)10-25(17)20(28)13-5-6-14(9-21)18(7-13)29-2/h5-7,11-12,15,17H,3-4,8-10,21H2,1-2H3,(H,22,27)	VCRLFUQSJVUXSF-UHFFFAOYSA-N	50533252	CHEMBL4457012	Serine protease 1	Homo sapiens		 2100							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533252	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533252&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155526172	440741834							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316885	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)n1cc(nn1)C1CC1 |r|	InChI=1S/C20H26N6O3/c1-22-19(27)17-8-15(26-11-16(23-24-26)12-3-4-12)10-25(17)20(28)13-5-6-14(9-21)18(7-13)29-2/h5-7,11-12,15,17H,3-4,8-10,21H2,1-2H3,(H,22,27)	VCRLFUQSJVUXSF-UHFFFAOYSA-N	50533252	CHEMBL4457012	Serine protease 1	Homo sapiens		 2100							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533252	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533252&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155526172	440741834							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316886	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Coagulation factor X	Homo sapiens		 72000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316887	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)n1cc(nn1)C1CC1 |r|	InChI=1S/C20H26N6O3/c1-22-19(27)17-8-15(26-11-16(23-24-26)12-3-4-12)10-25(17)20(28)13-5-6-14(9-21)18(7-13)29-2/h5-7,11-12,15,17H,3-4,8-10,21H2,1-2H3,(H,22,27)	VCRLFUQSJVUXSF-UHFFFAOYSA-N	50533252	CHEMBL4457012	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533252	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533252&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155526172	440741834							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316888	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Chymotrypsinogen B2	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316889	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Chymotrypsinogen B2	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316890	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Chymotrypsinogen B2	Homo sapiens		 15000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316891	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Neutrophil elastase	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316892	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Neutrophil elastase	Homo sapiens		 55000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316893	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Coagulation factor X	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316894	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Coagulation factor X	Homo sapiens		 71000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316895	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Prothrombin	Homo sapiens		 54000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316896	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Prothrombin	Homo sapiens		 94000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316897	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c2ccc(c(c2)OC)CN)N3CCc4c(ncnc4OCCC5CC5)C3	InChI=1S/C27H36N6O4/c1-29-25(34)23-12-20(14-33(23)27(35)18-5-6-19(13-28)24(11-18)36-2)32-9-7-21-22(15-32)30-16-31-26(21)37-10-8-17-3-4-17/h5-6,11,16-17,20,23H,3-4,7-10,12-15,28H2,1-2H3,(H,29,34)	PZBPHXPZLFDRAP-UHFFFAOYSA-N	50533257	CHEMBL4475942	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533257	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533257&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	6VZ	5LGO	121488126	440741839							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316898	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCc1ccccc1 |r|	InChI=1S/C32H38N4O4/c1-34-31(37)28-18-26(21-36(28)32(38)23-11-12-24(19-33)30(17-23)39-2)35-15-13-27-25(20-35)9-6-10-29(27)40-16-14-22-7-4-3-5-8-22/h3-12,17,26,28H,13-16,18-21,33H2,1-2H3,(H,34,37)	PAZGSUVUHZFUIE-UHFFFAOYSA-N	50533258	CHEMBL4435231	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533258	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533258&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155511048	440741840							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316899	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCC1CC1 |r|	InChI=1S/C29H38N4O4/c1-31-28(34)25-15-23(18-33(25)29(35)20-8-9-21(16-30)27(14-20)36-2)32-12-10-24-22(17-32)4-3-5-26(24)37-13-11-19-6-7-19/h3-5,8-9,14,19,23,25H,6-7,10-13,15-18,30H2,1-2H3,(H,31,34)	IXTGYRLHWAJSLD-UHFFFAOYSA-N	50533259	CHEMBL4528713	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 11000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533259	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533259&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155545015	440741841							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316900	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2ccccc2C1 |r|	InChI=1S/C24H30N4O3/c1-26-23(29)21-12-20(27-10-9-16-5-3-4-6-19(16)14-27)15-28(21)24(30)17-7-8-18(13-25)22(11-17)31-2/h3-8,11,20-21H,9-10,12-15,25H2,1-2H3,(H,26,29)	GUGQCVCWHLPKCI-UHFFFAOYSA-N	50533260	CHEMBL4515510	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533260	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533260&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155539794	440741842							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316901	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1C[C@H]1c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C28H32N6O3/c1-37-26-11-19(9-10-20(26)14-29)28(36)33-15-21(34-16-24(31-32-34)18-7-8-18)12-25(33)27(35)30-23-13-22(23)17-5-3-2-4-6-17/h2-6,9-11,16,18,21-23,25H,7-8,12-15,29H2,1H3,(H,30,35)	WACYIZDLHZRJIP-UHFFFAOYSA-N	50533261	CHEMBL4466010	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 22000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533261&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155531857	440741843							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316902	Cc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O2/c1-22-16-26(14-15-27(22)18-34)33(41)38-20-28(39-21-30(36-37-39)25-12-13-25)17-31(38)32(40)35-19-29(23-8-4-2-5-9-23)24-10-6-3-7-11-24/h2-11,14-16,21,25,28-29,31H,12-13,17-20,34H2,1H3,(H,35,40)	PZZNYPKBAWLPAM-UHFFFAOYSA-N	50533262	CHEMBL4581285	Serine protease 1	Homo sapiens		 110							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533262	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533262&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155561184	440741844							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316903	NCc1ccc(cc1F)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C32H33FN6O2/c33-28-15-24(13-14-25(28)17-34)32(41)38-19-26(39-20-29(36-37-39)23-11-12-23)16-30(38)31(40)35-18-27(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-10,13-15,20,23,26-27,30H,11-12,16-19,34H2,(H,35,40)	MEHFRWOKXZRGDA-UHFFFAOYSA-N	50533263	CHEMBL4440518	Serine protease 1	Homo sapiens		 31000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533263	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533263&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155514831	440741845							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316904	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Serine protease 1	Homo sapiens		 11							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316905	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1C[C@H]1c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C28H32N6O3/c1-37-26-11-19(9-10-20(26)14-29)28(36)33-15-21(34-16-24(31-32-34)18-7-8-18)12-25(33)27(35)30-23-13-22(23)17-5-3-2-4-6-17/h2-6,9-11,16,18,21-23,25H,7-8,12-15,29H2,1H3,(H,30,35)	WACYIZDLHZRJIP-UHFFFAOYSA-N	50533261	CHEMBL4466010	Serine protease 1	Homo sapiens		 110							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533261&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155531857	440741843							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316906	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Serine protease 1	Homo sapiens		 19							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316907	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2ccccc2C1 |r|	InChI=1S/C24H30N4O3/c1-26-23(29)21-12-20(27-10-9-16-5-3-4-6-19(16)14-27)15-28(21)24(30)17-7-8-18(13-25)22(11-17)31-2/h3-8,11,20-21H,9-10,12-15,25H2,1-2H3,(H,26,29)	GUGQCVCWHLPKCI-UHFFFAOYSA-N	50533260	CHEMBL4515510	Serine protease 1	Homo sapiens		 490							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533260	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533260&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155539794	440741842							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316908	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCC1CC1 |r|	InChI=1S/C29H38N4O4/c1-31-28(34)25-15-23(18-33(25)29(35)20-8-9-21(16-30)27(14-20)36-2)32-12-10-24-22(17-32)4-3-5-26(24)37-13-11-19-6-7-19/h3-5,8-9,14,19,23,25H,6-7,10-13,15-18,30H2,1-2H3,(H,31,34)	IXTGYRLHWAJSLD-UHFFFAOYSA-N	50533259	CHEMBL4528713	Serine protease 1	Homo sapiens		 2.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533259	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533259&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155545015	440741841							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316909	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c2ccc(c(c2)OC)CN)N3CCc4c(ncnc4OCCC5CC5)C3	InChI=1S/C27H36N6O4/c1-29-25(34)23-12-20(14-33(23)27(35)18-5-6-19(13-28)24(11-18)36-2)32-9-7-21-22(15-32)30-16-31-26(21)37-10-8-17-3-4-17/h5-6,11,16-17,20,23H,3-4,7-10,12-15,28H2,1-2H3,(H,29,34)	PZBPHXPZLFDRAP-UHFFFAOYSA-N	50533257	CHEMBL4475942	Serine protease 1	Homo sapiens		 6.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533257	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533257&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	6VZ	5LGO	121488126	440741839							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316910	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@H](C1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C29H34N6O3/c1-38-27-13-21(9-10-22(27)15-30)28(36)34-17-24(35-18-25(31-32-35)20-7-8-20)14-26(34)29(37)33-12-11-23(16-33)19-5-3-2-4-6-19/h2-6,9-10,13,18,20,23-24,26H,7-8,11-12,14-17,30H2,1H3	UOZIVEGXVLHOBN-UHFFFAOYSA-N	50533264	CHEMBL4558179	Serine protease 1	Homo sapiens		 330							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533264	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533264&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155557358	440741846							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316911	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@H]1C[C@@H]1c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C28H32N6O3/c1-37-26-11-19(9-10-20(26)14-29)28(36)33-15-21(34-16-24(31-32-34)18-7-8-18)12-25(33)27(35)30-23-13-22(23)17-5-3-2-4-6-17/h2-6,9-11,16,18,21-23,25H,7-8,12-15,29H2,1H3,(H,30,35)	WACYIZDLHZRJIP-UHFFFAOYSA-N	50533265	CHEMBL4532092	Serine protease 1	Homo sapiens		 960							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533265	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533265&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155546465	440741847							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316912	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 500							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316913	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C29H34N6O3/c1-38-27-13-21(9-10-22(27)15-30)28(36)34-17-24(35-18-25(31-32-35)20-7-8-20)14-26(34)29(37)33-12-11-23(16-33)19-5-3-2-4-6-19/h2-6,9-10,13,18,20,23-24,26H,7-8,11-12,14-17,30H2,1H3	UOZIVEGXVLHOBN-UHFFFAOYSA-N	50533266	CHEMBL4475317	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 14000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533266	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533266&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155537382	440741848							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316914	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Coagulation factor X	Homo sapiens		 31000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316915	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 12000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316916	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCc1ccccc1 |r|	InChI=1S/C32H38N4O4/c1-34-31(37)28-18-26(21-36(28)32(38)23-11-12-24(19-33)30(17-23)39-2)35-15-13-27-25(20-35)9-6-10-29(27)40-16-14-22-7-4-3-5-8-22/h3-12,17,26,28H,13-16,18-21,33H2,1-2H3,(H,34,37)	PAZGSUVUHZFUIE-UHFFFAOYSA-N	50533258	CHEMBL4435231	Serine protease 1	Homo sapiens		 3.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533258	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533258&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155511048	440741840							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316917	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Chymotrypsinogen B2	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316918	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 12000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316919	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C29H34N6O3/c1-38-27-13-21(9-10-22(27)15-30)28(36)34-17-24(35-18-25(31-32-35)20-7-8-20)14-26(34)29(37)33-12-11-23(16-33)19-5-3-2-4-6-19/h2-6,9-10,13,18,20,23-24,26H,7-8,11-12,14-17,30H2,1H3	UOZIVEGXVLHOBN-UHFFFAOYSA-N	50533266	CHEMBL4475317	Serine protease 1	Homo sapiens		 220							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533266	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533266&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155537382	440741848							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316920	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Chymotrypsinogen B2	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316921	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Chymotrypsinogen B2	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316922	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Chymotrypsinogen B2	Homo sapiens		 15000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316923	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Neutrophil elastase	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316924	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Neutrophil elastase	Homo sapiens		 55000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316925	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Coagulation factor X	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316926	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Coagulation factor X	Homo sapiens		 71000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316927	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Prothrombin	Homo sapiens		 54000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316928	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Prothrombin	Homo sapiens		 94000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316929	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c2ccc(c(c2)OC)CN)N3CCc4c(ncnc4OCCC5CC5)C3	InChI=1S/C27H36N6O4/c1-29-25(34)23-12-20(14-33(23)27(35)18-5-6-19(13-28)24(11-18)36-2)32-9-7-21-22(15-32)30-16-31-26(21)37-10-8-17-3-4-17/h5-6,11,16-17,20,23H,3-4,7-10,12-15,28H2,1-2H3,(H,29,34)	PZBPHXPZLFDRAP-UHFFFAOYSA-N	50533257	CHEMBL4475942	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533257	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533257&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	6VZ	5LGO	121488126	440741839							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316930	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCc1ccccc1 |r|	InChI=1S/C32H38N4O4/c1-34-31(37)28-18-26(21-36(28)32(38)23-11-12-24(19-33)30(17-23)39-2)35-15-13-27-25(20-35)9-6-10-29(27)40-16-14-22-7-4-3-5-8-22/h3-12,17,26,28H,13-16,18-21,33H2,1-2H3,(H,34,37)	PAZGSUVUHZFUIE-UHFFFAOYSA-N	50533258	CHEMBL4435231	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533258	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533258&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155511048	440741840							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316931	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCC1CC1 |r|	InChI=1S/C29H38N4O4/c1-31-28(34)25-15-23(18-33(25)29(35)20-8-9-21(16-30)27(14-20)36-2)32-12-10-24-22(17-32)4-3-5-26(24)37-13-11-19-6-7-19/h3-5,8-9,14,19,23,25H,6-7,10-13,15-18,30H2,1-2H3,(H,31,34)	IXTGYRLHWAJSLD-UHFFFAOYSA-N	50533259	CHEMBL4528713	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 11000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533259	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533259&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155545015	440741841							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316932	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2ccccc2C1 |r|	InChI=1S/C24H30N4O3/c1-26-23(29)21-12-20(27-10-9-16-5-3-4-6-19(16)14-27)15-28(21)24(30)17-7-8-18(13-25)22(11-17)31-2/h3-8,11,20-21H,9-10,12-15,25H2,1-2H3,(H,26,29)	GUGQCVCWHLPKCI-UHFFFAOYSA-N	50533260	CHEMBL4515510	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533260	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533260&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155539794	440741842							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316933	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1C[C@H]1c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C28H32N6O3/c1-37-26-11-19(9-10-20(26)14-29)28(36)33-15-21(34-16-24(31-32-34)18-7-8-18)12-25(33)27(35)30-23-13-22(23)17-5-3-2-4-6-17/h2-6,9-11,16,18,21-23,25H,7-8,12-15,29H2,1H3,(H,30,35)	WACYIZDLHZRJIP-UHFFFAOYSA-N	50533261	CHEMBL4466010	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 22000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533261&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155531857	440741843							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316934	Cc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O2/c1-22-16-26(14-15-27(22)18-34)33(41)38-20-28(39-21-30(36-37-39)25-12-13-25)17-31(38)32(40)35-19-29(23-8-4-2-5-9-23)24-10-6-3-7-11-24/h2-11,14-16,21,25,28-29,31H,12-13,17-20,34H2,1H3,(H,35,40)	PZZNYPKBAWLPAM-UHFFFAOYSA-N	50533262	CHEMBL4581285	Serine protease 1	Homo sapiens		 110							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533262	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533262&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155561184	440741844							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316935	NCc1ccc(cc1F)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C32H33FN6O2/c33-28-15-24(13-14-25(28)17-34)32(41)38-19-26(39-20-29(36-37-39)23-11-12-23)16-30(38)31(40)35-18-27(21-7-3-1-4-8-21)22-9-5-2-6-10-22/h1-10,13-15,20,23,26-27,30H,11-12,16-19,34H2,(H,35,40)	MEHFRWOKXZRGDA-UHFFFAOYSA-N	50533263	CHEMBL4440518	Serine protease 1	Homo sapiens		 31000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533263	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533263&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155514831	440741845							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316936	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Serine protease 1	Homo sapiens		 11							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316937	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@@H]1C[C@H]1c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C28H32N6O3/c1-37-26-11-19(9-10-20(26)14-29)28(36)33-15-21(34-16-24(31-32-34)18-7-8-18)12-25(33)27(35)30-23-13-22(23)17-5-3-2-4-6-17/h2-6,9-11,16,18,21-23,25H,7-8,12-15,29H2,1H3,(H,30,35)	WACYIZDLHZRJIP-UHFFFAOYSA-N	50533261	CHEMBL4466010	Serine protease 1	Homo sapiens		 110							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533261&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155531857	440741843							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316938	COc1cc(ccc1CN)C(=O)N2C[C@H](C[C@H]2C(=O)N[C@H]3CCCC[C@@H]3c4ccccc4)n5cc(nn5)C6CC6	InChI=1S/C31H38N6O3/c1-40-29-15-22(13-14-23(29)17-32)31(39)36-18-24(37-19-27(34-35-37)21-11-12-21)16-28(36)30(38)33-26-10-6-5-9-25(26)20-7-3-2-4-8-20/h2-4,7-8,13-15,19,21,24-26,28H,5-6,9-12,16-18,32H2,1H3,(H,33,38)	AYVQDWAWTUYBGU-UHFFFAOYSA-N	50533253	CHEMBL4441232	Serine protease 1	Homo sapiens		 19							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533253&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	6WH	5LH8	121488127	440741835							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316939	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2ccccc2C1 |r|	InChI=1S/C24H30N4O3/c1-26-23(29)21-12-20(27-10-9-16-5-3-4-6-19(16)14-27)15-28(21)24(30)17-7-8-18(13-25)22(11-17)31-2/h3-8,11,20-21H,9-10,12-15,25H2,1-2H3,(H,26,29)	GUGQCVCWHLPKCI-UHFFFAOYSA-N	50533260	CHEMBL4515510	Serine protease 1	Homo sapiens		 490							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533260	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533260&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155539794	440741842							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316940	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCC1CC1 |r|	InChI=1S/C29H38N4O4/c1-31-28(34)25-15-23(18-33(25)29(35)20-8-9-21(16-30)27(14-20)36-2)32-12-10-24-22(17-32)4-3-5-26(24)37-13-11-19-6-7-19/h3-5,8-9,14,19,23,25H,6-7,10-13,15-18,30H2,1-2H3,(H,31,34)	IXTGYRLHWAJSLD-UHFFFAOYSA-N	50533259	CHEMBL4528713	Serine protease 1	Homo sapiens		 2.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533259	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533259&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155545015	440741841							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316941	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c2ccc(c(c2)OC)CN)N3CCc4c(ncnc4OCCC5CC5)C3	InChI=1S/C27H36N6O4/c1-29-25(34)23-12-20(14-33(23)27(35)18-5-6-19(13-28)24(11-18)36-2)32-9-7-21-22(15-32)30-16-31-26(21)37-10-8-17-3-4-17/h5-6,11,16-17,20,23H,3-4,7-10,12-15,28H2,1-2H3,(H,29,34)	PZBPHXPZLFDRAP-UHFFFAOYSA-N	50533257	CHEMBL4475942	Serine protease 1	Homo sapiens		 6.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533257	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533257&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	6VZ	5LGO	121488126	440741839							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316942	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@H](C1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C29H34N6O3/c1-38-27-13-21(9-10-22(27)15-30)28(36)34-17-24(35-18-25(31-32-35)20-7-8-20)14-26(34)29(37)33-12-11-23(16-33)19-5-3-2-4-6-19/h2-6,9-10,13,18,20,23-24,26H,7-8,11-12,14-17,30H2,1H3	UOZIVEGXVLHOBN-UHFFFAOYSA-N	50533264	CHEMBL4558179	Serine protease 1	Homo sapiens		 330							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533264	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533264&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155557358	440741846							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316943	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N[C@H]1C[C@@H]1c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C28H32N6O3/c1-37-26-11-19(9-10-20(26)14-29)28(36)33-15-21(34-16-24(31-32-34)18-7-8-18)12-25(33)27(35)30-23-13-22(23)17-5-3-2-4-6-17/h2-6,9-11,16,18,21-23,25H,7-8,12-15,29H2,1H3,(H,30,35)	WACYIZDLHZRJIP-UHFFFAOYSA-N	50533265	CHEMBL4532092	Serine protease 1	Homo sapiens		 960							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533265	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533265&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155546465	440741847							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316944	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 500							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316945	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C29H34N6O3/c1-38-27-13-21(9-10-22(27)15-30)28(36)34-17-24(35-18-25(31-32-35)20-7-8-20)14-26(34)29(37)33-12-11-23(16-33)19-5-3-2-4-6-19/h2-6,9-10,13,18,20,23-24,26H,7-8,11-12,14-17,30H2,1H3	UOZIVEGXVLHOBN-UHFFFAOYSA-N	50533266	CHEMBL4475317	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 14000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533266	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533266&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155537382	440741848							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316946	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Neutrophil elastase	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316947	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Neutrophil elastase	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316948	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Prothrombin	Homo sapiens		 27000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316949	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)ncnc2OCCc1ccccc1 |r|	InChI=1S/C30H36N6O4/c1-32-28(37)26-15-23(17-36(26)30(38)21-8-9-22(16-31)27(14-21)39-2)35-12-10-24-25(18-35)33-19-34-29(24)40-13-11-20-6-4-3-5-7-20/h3-9,14,19,23,26H,10-13,15-18,31H2,1-2H3,(H,32,37)	YAGYIYAXSJVTKY-UHFFFAOYSA-N	50533267	CHEMBL4443722	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533267	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533267&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155516645	440741849							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316950	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316951	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Serine protease 1	Homo sapiens		 110							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316952	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCCc1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C27H32N6O3/c1-36-25-13-20(9-10-21(25)15-28)27(35)32-16-22(33-17-23(30-31-33)19-7-8-19)14-24(32)26(34)29-12-11-18-5-3-2-4-6-18/h2-6,9-10,13,17,19,22,24H,7-8,11-12,14-16,28H2,1H3,(H,29,34)	CYEYRTLTAZPJTL-UHFFFAOYSA-N	50533268	CHEMBL4557806	Serine protease 1	Homo sapiens		 160							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533268	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533268&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155554542	440741850							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316953	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Serine protease 1	Homo sapiens		 8.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316954	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)ncnc2OCCc1ccccc1 |r|	InChI=1S/C30H36N6O4/c1-32-28(37)26-15-23(17-36(26)30(38)21-8-9-22(16-31)27(14-21)39-2)35-12-10-24-25(18-35)33-19-34-29(24)40-13-11-20-6-4-3-5-7-20/h3-9,14,19,23,26H,10-13,15-18,31H2,1-2H3,(H,32,37)	YAGYIYAXSJVTKY-UHFFFAOYSA-N	50533267	CHEMBL4443722	Serine protease 1	Homo sapiens		 5.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533267	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533267&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155516645	440741849							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316955	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2400							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316956	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Neutrophil elastase	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316957	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Neutrophil elastase	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5023&target=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Neutrophil+elastase&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MTLGRRLACLFLACVLPALLLGGTALASEIVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRAVRVVLGAHNLSRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSLCRRSNVCTLVRGRQAGVCFGDSGSPLVCNGLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSIIQRSEDNPCPHPRDPDPASRTH	7WHU,7CBK,9SI4,9ATU,9ATK,9ASX,9ASS,8VK5,8QGX,8G26,8G25,8G24,8D7K,8D7I,8D4U,8D4Q,6SMA,6F5M,6E69,5ABW,5A8Z,5A8Y,5A8X,5A0C,5A0B,5A0A,5A09,4WVP,4NZL,3Q77,3Q76,2Z7F,2RG3,1PPG,1PPF,1H1B	Neutrophil elastase	ELNE_HUMAN	P08246	P09649 Q6B0D9 Q6LDP5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316958	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Prothrombin	Homo sapiens		 27000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316959	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)ncnc2OCCc1ccccc1 |r|	InChI=1S/C30H36N6O4/c1-32-28(37)26-15-23(17-36(26)30(38)21-8-9-22(16-31)27(14-21)39-2)35-12-10-24-25(18-35)33-19-34-29(24)40-13-11-20-6-4-3-5-7-20/h3-9,14,19,23,26H,10-13,15-18,31H2,1-2H3,(H,32,37)	YAGYIYAXSJVTKY-UHFFFAOYSA-N	50533267	CHEMBL4443722	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533267	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533267&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155516645	440741849							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316960	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316961	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Serine protease 1	Homo sapiens		 110							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316962	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCCc1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C27H32N6O3/c1-36-25-13-20(9-10-21(25)15-28)27(35)32-16-22(33-17-23(30-31-33)19-7-8-19)14-24(32)26(34)29-12-11-18-5-3-2-4-6-18/h2-6,9-10,13,17,19,22,24H,7-8,11-12,14-16,28H2,1H3,(H,29,34)	CYEYRTLTAZPJTL-UHFFFAOYSA-N	50533268	CHEMBL4557806	Serine protease 1	Homo sapiens		 160							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533268	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533268&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155554542	440741850							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316963	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Serine protease 1	Homo sapiens		 8.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316964	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)ncnc2OCCc1ccccc1 |r|	InChI=1S/C30H36N6O4/c1-32-28(37)26-15-23(17-36(26)30(38)21-8-9-22(16-31)27(14-21)39-2)35-12-10-24-25(18-35)33-19-34-29(24)40-13-11-20-6-4-3-5-7-20/h3-9,14,19,23,26H,10-13,15-18,31H2,1-2H3,(H,32,37)	YAGYIYAXSJVTKY-UHFFFAOYSA-N	50533267	CHEMBL4443722	Serine protease 1	Homo sapiens		 5.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533267	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533267&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155516645	440741849							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316965	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2400							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316966	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Prothrombin	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316967	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OC |r|	InChI=1S/C25H32N4O4/c1-27-24(30)21-12-19(28-10-9-20-18(14-28)5-4-6-22(20)32-2)15-29(21)25(31)16-7-8-17(13-26)23(11-16)33-3/h4-8,11,19,21H,9-10,12-15,26H2,1-3H3,(H,27,30)	BOAPOFHCSRPKBE-UHFFFAOYSA-N	50533269	CHEMBL4472682	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533269	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533269&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155536057	440741851							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316968	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCOC |r|	InChI=1S/C27H36N4O5/c1-29-26(32)23-14-21(17-31(23)27(33)18-7-8-19(15-28)25(13-18)35-3)30-10-9-22-20(16-30)5-4-6-24(22)36-12-11-34-2/h4-8,13,21,23H,9-12,14-17,28H2,1-3H3,(H,29,32)	OBAPCSRNRUUGDW-UHFFFAOYSA-N	50533254	CHEMBL4550207	Prothrombin	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=334&target=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533254&enzyme=Prothrombin&column=ki&startPg=0&Increment=50&submit=Search			155550748	440741836							1	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE	9CMO,9CLS,9CLN,8RTN,8UF7,4O03,4NZQ,1XM1,1JWT,1HAG,1DOJ,1NU9,6V5T,2BDY,1D9I,3C1K,1ZRB,1ZGV,1ZGI,1Z71,1TA6,1TA2,1SL3,1NT1,1NM6,1G37,1D6W,9R8Q,9H79,9H5N,9C50,8BW5,8ASF,8ASE,7ZKO,7ZKN,7ZKM,7ZKL,7PHX,7NTU,7MJ5,7KME,7AC9,6ZV8,6ZV7,6ZUX,6ZUW,6ZUU,6ZUN,6ZUH,6ZGO,6Z8X,6Z8W,6Z8V,6Z48,6YSX,6YSJ,6YQV,6YN3,6YMP,6YHJ,6YHG,6YB6,6Y9H,6Y02,6V64,6TKL,6TKJ,6TKI,6TKH,6TKG,6TDT,6T8A,6T89,6T7H,6T57,6T56,6T55,6T54,6T53,6T52,6T4A,6T3Q,6T3M,6I51,6HSX,6GWE,6GN7,6GBW,6EVV,6EO9,6EO8,6EO7,6EO6,6CYM,5NHU,5LPD,5LCE,5L6N,5JZY,5JFD,5GIM,5GDS,5EW2,5EW1,5E8E,5CMX,4YES,4UD9,4THN,4LZ4,4LZ1,4LXB,4I7Y,4HTC,4E7R,4E06,4E05,4DII,4DIH,4CH8,4CH2,4BOH,4BAQ,4BAO,4BAN,4BAM,4BAK,4BAH,3VXF,3VXE,3UWJ,3UTU,3U9A,3U98,3U8T,3U8R,3U8O,3U69,3TU7,3T5F,3SV2,3SI4,3SI3,3SHC,3SHA,3RMO,3RMN,3RMM,3RML,3RM2,3RM0,3RLY,3RLW,3QX5,3QWC,3QTV,3QTO,3QLP,3PMH,3P70,3P6Z,3P17,3LDX,3HTC,3HAT,3F68,3EQ0,3EGK,3E6P,3DUX,3DT0,3DHK,3DA9,3D49,3C27,3BF6,3B23,2ZO3,2ZNK,2ZIQ,2ZI2,2ZHW,2ZHQ,2ZHF,2ZHE,2ZGX,2ZGB,2ZG0,2ZFR,2ZFQ,2ZFP,2ZFF,2ZF0,2ZDV,2ZDA,2ZC9,2UUK,2UUJ,2UUF,2R2M,2JH6,2JH5,2JH0,2HPQ,2HPP,2HGT,2H9T,2GDE,2FES,2FEQ,2C93,2C90,2C8Z,2C8Y,2C8X,2C8W,2BXU,2BXT,2BVX,2BVS,2ANK,2AFQ,2A45,2A2X,1XMN,1WAY,1W7G,1UVS,1UMA,1TOM,1TMU,1TMT,1TMB,1THS,1THR,1TBZ,1T4V,1T4U,1SR5,1QJ7,1QJ6,1QJ1,1QHR,1QBV,1PPB,1P8V,1OYT,1OOK,1O5G,1O2G,1O0D,1NZQ,1NU7,1NRS,1NRR,1NRQ,1NRP,1NRO,1NRN,1NO9,1MUE,1MU8,1MU6,1LHG,1LHF,1LHE,1LHD,1LHC,1KTT,1KTS,1K22,1K21,1IHT,1IHS,1HXF,1HXE,1HUT,1HLT,1HGT,1HDT,1HBT,1HAP,1HAO,1HAI,1HAH,1G32,1G30,1FPH,1FPC,1DWE,1DWD,1DWC,1DWB,1DIT,1DE7,1D4P,1D3T,1D3Q,1D3P,1CA8,1C5O,1C5N,1C5L,1C1W,1C1V,1C1U,1BMN,1BMM,1BCU,1BB0,1BA8,1B5G,1AY6,1AWH,1AWF,1AIX,1AI8,1AHT,1AFE,1AE8,1AD8,1ABJ,1ABI,1A61,1A5G,1A4W,1A46,1A3E,1A3B,1A2C,6PXJ,6ZUG,5DO4,5AHG,5AFZ,5AFY,5AF9,5A2M,4UFG,4UFF,4UFE,4UFD,4UEH,4UE7,4UDW,3DD2,2PW8,1SB1,1GJ5,1GJ4,4LOY,4AZ2,4AYY,4AYV,4AX9,3BIV,3BIU	Prothrombin	THRB_HUMAN	P00734	B2R7F7 B4E1A7 Q4QZ40 Q53H04 Q53H06 Q69EZ7 Q7Z7P3 Q9UCA1																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316969	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OC |r|	InChI=1S/C25H32N4O4/c1-27-24(30)21-12-19(28-10-9-20-18(14-28)5-4-6-22(20)32-2)15-29(21)25(31)16-7-8-17(13-26)23(11-16)33-3/h4-8,11,19,21H,9-10,12-15,26H2,1-3H3,(H,27,30)	BOAPOFHCSRPKBE-UHFFFAOYSA-N	50533269	CHEMBL4472682	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>30000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533269	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533269&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155536057	440741851							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G	Voltage-gated inwardly rectifying potassium channel KCNH2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Voltage-gated inwardly rectifying potassium channel KCNH2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
51316970	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OC |r|	InChI=1S/C25H32N4O4/c1-27-24(30)21-12-19(28-10-9-20-18(14-28)5-4-6-22(20)32-2)15-29(21)25(31)16-7-8-17(13-26)23(11-16)33-3/h4-8,11,19,21H,9-10,12-15,26H2,1-3H3,(H,27,30)	BOAPOFHCSRPKBE-UHFFFAOYSA-N	50533269	CHEMBL4472682	Serine protease 1	Homo sapiens		 100							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533269	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533269&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155536057	440741851							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316971	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OC |r|	InChI=1S/C25H32N4O4/c1-27-24(30)21-12-19(28-10-9-20-18(14-28)5-4-6-22(20)32-2)15-29(21)25(31)16-7-8-17(13-26)23(11-16)33-3/h4-8,11,19,21H,9-10,12-15,26H2,1-3H3,(H,27,30)	BOAPOFHCSRPKBE-UHFFFAOYSA-N	50533269	CHEMBL4472682	Serine protease 1	Homo sapiens		 100							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533269	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533269&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155536057	440741851							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316972	c1ccc(cc1)C(CNC(=O)[C@@H]2C[C@@H](CN2C(=O)c3ccc(cc3)CN)n4cc(nn4)C5CC5)c6ccccc6	InChI=1S/C32H34N6O2/c33-18-22-11-13-26(14-12-22)32(40)37-20-27(38-21-29(35-36-38)25-15-16-25)17-30(37)31(39)34-19-28(23-7-3-1-4-8-23)24-9-5-2-6-10-24/h1-14,21,25,27-28,30H,15-20,33H2,(H,34,39)	YBZBHUMSHGXQNF-UHFFFAOYSA-N	50533256	CHEMBL4448473	Chymotrypsinogen B2	Homo sapiens		>100000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50000309&target=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533256&enzyme=Chymotrypsinogen+B2&column=ki&startPg=0&Increment=50&submit=Search	6W4	5LH4	131955087	440741838							1	MAFLWLLSCWALLGTTFGCGVPAIHPVLSGLSRIVNGEDAVPGSWPWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVRTSDVVVAGEFDQGSDEENIQVLKIAKVFKNPKFSILTVNNDITLLKLATPARFSQTVSAVCLPSADDDFPAGTLCATTGWGKTKYNANKTPDKLQQAALPLLSNAECKKSWGRRITDVMICAGASGVSSCMGDSGGPLVCQKDGAWTLVGIVSWGSRTCSTTTPAVYARVAKLIPWVQKILAAN		Chymotrypsinogen B2	CTRB2_HUMAN	Q6GPI1	A8K707																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316973	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)N1CC[C@@H](C1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C29H34N6O3/c1-38-27-13-21(9-10-22(27)15-30)28(36)34-17-24(35-18-25(31-32-35)20-7-8-20)14-26(34)29(37)33-12-11-23(16-33)19-5-3-2-4-6-19/h2-6,9-10,13,18,20,23-24,26H,7-8,11-12,14-17,30H2,1H3	UOZIVEGXVLHOBN-UHFFFAOYSA-N	50533266	CHEMBL4475317	Serine protease 1	Homo sapiens		 220							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533266	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533266&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155537382	440741848							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316974	COc1cc(ccc1CN)C(=O)N1C[C@H](C[C@H]1C(=O)NCC(c1ccccc1)c1ccccc1)n1cc(nn1)C1CC1 |r|	InChI=1S/C33H36N6O3/c1-42-31-16-25(14-15-26(31)18-34)33(41)38-20-27(39-21-29(36-37-39)24-12-13-24)17-30(38)32(40)35-19-28(22-8-4-2-5-9-22)23-10-6-3-7-11-23/h2-11,14-16,21,24,27-28,30H,12-13,17-20,34H2,1H3,(H,35,40)	ZXPHIYQTYJUUQW-UHFFFAOYSA-N	50533255	CHEMBL4476255	Coagulation factor X	Homo sapiens		 31000							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1341&target=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533255&enzyme=Coagulation+factor+X&column=ki&startPg=0&Increment=50&submit=Search			146680900	440741837							1	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK	9L6S,9CM9,9CM2,9CLI,8EOK,4ZHA,4ZH8,4Y7B,4Y7A,4Y79,4Y76,4Y71,4Y6D,4BTU,4BTT,4BTI,4A7I,2Y82,2Y81,2Y80,2Y7Z,2Y7X,2WYJ,2WYG,2VH6,2VH0,2UWP,2UWO,2UWL,2J95,2J94,2J4I,2J38,2J34,2J2U,2CJI,2BOH,1P0S,1NFY,1NFX,1NFW,1NFU,1LQD,1LPZ,1LPK,1LPG,1KSN,1F0S,1F0R,1EZQ,7TPP,1FAX,1C5M,9I24,2BQW,2BQ7,2BQ6,7AHU,3KL6,2XC5,2XC4,2XC0,2XBY,2XBX,2XBW,1HCG,3SW2,3K9X,3HPT,3ENS,2P3F,1XKB,1XKA,1IQN,1IQM,1IQL,1IQK,1IQJ,1IQI,1IQH,1IQG,1IQF,1IQE,1IOE,1G2M,1G2L,9CTH,9R8R,5K0H,3M37,3M36,3LIW,3KQE,3KQD,3KQC,3KQB,3FFG,3CS7,3CEN,2W3K,2W3I,2W26,2RA0,2Q1J,2PR3,2PHB,2P95,2P94,2P93,2P16,2G00,2FZZ,2BMG,1Z6E,1FJS,3TK6,3TK5,3Q3K,3IIT,2P3U,2P3T,2H9E,2EI8,2EI7,2EI6,2D1J,1WU1,1V3X,1MQ6,1MQ5,5VOF,5VOE,9P0X	Coagulation factor X	FA10_HUMAN	P00742	Q14340																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
51316975	CNC(=O)[C@@H]1C[C@@H](CN1C(=O)c1ccc(CN)c(OC)c1)N1CCc2c(C1)cccc2OCCc1ccccc1 |r|	InChI=1S/C32H38N4O4/c1-34-31(37)28-18-26(21-36(28)32(38)23-11-12-24(19-33)30(17-23)39-2)35-15-13-27-25(20-35)9-6-10-29(27)40-16-14-22-7-4-3-5-8-22/h3-12,17,26,28H,13-16,18-21,33H2,1-2H3,(H,34,37)	PAZGSUVUHZFUIE-UHFFFAOYSA-N	50533258	CHEMBL4435231	Serine protease 1	Homo sapiens		 3.0							ChEMBL	10.1016/j.bmcl.2016.07.029	10.7270/Q24X5C9N	27476144			Brandl, T; Simic, O; Skaanderup, PR; Namoto, K; Berst, F; Ehrhardt, C; Schiering, N; Mueller, I; Woelcke, J	9/1/2016	2/27/2021	Novartis Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50533258	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1529&target=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50533258&enzyme=Serine+protease+1&column=ki&startPg=0&Increment=50&submit=Search			155511048	440741840							1	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS	8ZJ4,8ZIY,8ZIV,8ZI4,8H3S,1TRN,2RA3,4WWY	Serine protease 1	TRY1_HUMAN	P07477	A1A509 A6NJ71 B2R5I5 Q5NV57 Q7M4N3 Q7M4N4 Q92955 Q9HAN4 Q9HAN5 Q9HAN6 Q9HAN7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
